Narendra D. Lalwani, Ph.D., FAHA, DABT
2015
In 2015, Narendra D. Lalwani, Ph.D., FAHA, DABT earned a total compensation of $3.2M as Executive Vice President, Research and Development and Chief Operating Officer at Esperion Therapeutics.
Compensation breakdown
| Bonus | $127,000 |
|---|---|
| Option Awards | $2,722,224 |
| Salary | $370,000 |
| Other | $12,000 |
| Total | $3,231,224 |
DABT received $2.7M in option awards, accounting for 84% of the total pay in 2015.
DABT also received $127K in bonus, $370K in salary and $12K in other compensation.
Rankings
In 2015, Narendra D. Lalwani, Ph.D., FAHA, DABT's compensation ranked 2,892nd out of 13,638 executives tracked by ExecPay. In other words, DABT earned more than 78.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,892 out of 13,638 | 79th |
Division Manufacturing | 1,025 out of 5,187 | 80th |
Major group Chemicals And Allied Products | 380 out of 1,857 | 80th |
Industry group Drugs | 297 out of 1,531 | 81st |
Industry Pharmaceutical Preparations | 236 out of 1,179 | 80th |
Source: SEC filing on April 13, 2018.
DABT's colleagues
We found four more compensation records of executives who worked with Narendra D. Lalwani, Ph.D., FAHA, DABT at Esperion Therapeutics in 2015.